000 04313nam a22005775i 4500
001 978-3-031-65937-9
003 DE-He213
005 20251030114638.0
007 cr nn 008mamaa
008 241225s2024 sz | s |||| 0|eng d
020 _a9783031659379
_9978-3-031-65937-9
024 7 _a10.1007/978-3-031-65937-9
_2doi
050 4 _aQA276-280
072 7 _aPBT
_2bicssc
072 7 _aMAT029000
_2bisacsh
072 7 _aPBT
_2thema
245 1 0 _aBiostatistics in Biopharmaceutical Research and Development
_h[electronic resource] :
_bClinical Trial Analysis, Volume 2 /
_cedited by Ding-Geng Chen.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXVIII, 517 p. 168 illus.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aStatistical Challenges in the Analysis of Biomarker Data -- 2. Evaluating Predictive Accuracy of Prognostic Model for Censored Time-to-Event Data Analysis in Clinical Trials -- Statistical Methods for Accommodating Immortal Time: A Selective Review and Comparison -- Variable selection for partially functional additive Cox Model with interval-censored failure time data -- A Bayesian proportional hazards model to predict patient recruitment in multicenter clinical trials -- GET MORE INFORMATION FROM RECURRENT EVENTS DATA -- Introduction to Patient Preference Studies -- Machine Learning for Precision Medicine and Humanized AI for Future Healthcare -- The Statistical Evaluation of Surrogate Endpoints in Clinical Trials -- Treatment Effect Estimation Using Data from Observational and Non-Randomized Studies -- Methods for Comparing Two Treatments for a Dichotomous Outcome for a Two-Period Design with Treatment Switching of Control Group Period 1 Non-Responders -- Regression-based estimation of optimal adaptive treatment strategies: Key methods -- Vaccine Disease-Prevention Efficacy Studies: Traditional Approaches and New Frontiers -- Covariate Adjustment in Analyzing Randomized Clinical Trials: Approaches, Software, and Application -- Joint correlated responses and feedback effect with time-dependent covariates -- Distributions and Their Approximations for P-Values.
520 _aThe Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 2 covers Biomarkers in Drug Development, Time-To-Event Data Analysis and Methods, and emerging development in biopharmaceutical biostatistics. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development. .
650 0 _aStatistics .
_965982
650 0 _aBiometry.
_965981
650 0 _aClinical medicine
_xResearch.
_974123
650 0 _aSampling (Statistics).
_959805
650 0 _aPublic health.
_961312
650 1 4 _aStatistics.
_965982
650 2 4 _aBiostatistics.
_965985
650 2 4 _aClinical Research.
_974124
650 2 4 _aMethodology of Data Collection and Processing.
_965946
650 2 4 _aSurvey Methodology.
_974358
650 2 4 _aPublic Health.
_961312
700 1 _aChen, Ding-Geng.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_980220
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031659362
776 0 8 _iPrinted edition:
_z9783031659386
776 0 8 _iPrinted edition:
_z9783031659393
856 4 0 _uhttps://doi.org/10.1007/978-3-031-65937-9
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c66020
_d66020